Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Categories:
Transfection
Authors:
Grzybek M1, Golonko A2, Górska A3, Szczepaniak K3, Strachecka A4, Lass A5, Lisowski P6,7.
In:
Biotechnology Journal (2018) 102: 11
Categories:
Transfection
Authors:
Aly AS, Mikolajczak SA, Rivera HS, Camargo N, Jacobs-Lorena V, Labaied M, Coppens I, Kappe SH
In:
Mol Microbiol (2008) 69(1): 152-63
Categories:
Transfection
Authors:
Labaied M, Harupa A, Dumpit RF, Coppens I, Mikolajczak SA, Kappe SH
In:
Infect Immun (2007) 75(8): 3758-68
Categories:
Transfection
Authors:
Ono T, Tadakuma T, Rodriguez A
In:
Exp Parasitol (2007) 115(3): 310-3
Categories:
Transfection
Authors:
Jongco AM, Ting LM, Thathy V, Mota MM, Kim K
In:
Mol Biochem Parasitol (2006) 146(2): 242-250
Categories:
Transfection
Authors:
Janse CJ, Franke-Fayard B, Mair GR, Ramesar J, Thiel C, Engelmann S, Matuschewski K, Gemert GJ, Sauerwein RW and Waters AP
In:
Mol Biochem Parasitol (2006) 145(1): 60-70
Categories:
Transfection
Authors:
Reininger L, Billker O, Tewari R, Mukhopadhyay A, Fennell C, Dorin-Semblat D, Doerig C, Goldring D, Harmse L, Ranford-Cartwright L, Packer J and Doerig C
In:
J Biol Chem (2005) 280(36): 31957-31964
+ Show All